Successful rechallenge of Panitumumab following severe infusion related reactions with Cetuximab

Event ESMO Preceptorhsip on Immunotherapy of Cancer Lund
Session Session 7 Practical Issues
Topics Cancer Immunology and Immunotherapy
Anti-Cancer Agents & Biologic Therapy
Presenter D. Biswajit, IN